Kirin (OTCMKTS:KNBWY) Shares Gap Up – Time to Buy?

Kirin Holdings Co. (OTCMKTS:KNBWY – Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $18.71, but opened at $19.5935. Kirin shares last traded at $19.6950, with a volume of 1,702 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Kirin from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 29th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

View Our Latest Stock Report on Kirin

Kirin Price Performance

The company has a market capitalization of $15.99 billion, a PE ratio of 13.07 and a beta of 0.05. The firm has a fifty day moving average of $18.40 and a two-hundred day moving average of $17.39. The company has a current ratio of 1.48, a quick ratio of 1.02 and a debt-to-equity ratio of 0.48.

Kirin (OTCMKTS:KNBWY – Get Free Report) last announced its quarterly earnings results on Wednesday, November 11th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.09. Kirin had a return on equity of 11.54% and a net margin of 7.58%. The business had revenue of $3.99 billion for the quarter, compared to analysts’ expectations of $4.04 billion. Research analysts anticipate that Kirin Holdings Co. will post 1.32 EPS for the current fiscal year.

Kirin Company Profile

(Get Free Report)

Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Featured Stories

Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with MarketBeat.com's FREE daily email newsletter.